CDKL5 Deficiency Disorder (CDD): A Patient Guide
At a Glance
CDKL5 deficiency disorder is a lifelong genetic condition marked by early, often hard-to-control seizures and developmental challenges, including low muscle tone, movement, vision, feeding, digestion, and sleep problems. Care aims to improve seizures, comfort, engagement, and quality of life.
CDKL5 Deficiency Disorder (CDD) is a rare, lifelong condition that fundamentally changes how the brain develops and communicates. It is classified as a developmental and epileptic encephalopathy (DEE), a term that describes a dual challenge: the underlying genetic variant itself causes developmental impairment by disrupting early brain growth, while frequent, intense seizure activity can place an additional burden on a child’s ability to learn and reach milestones [1]. Because the CDKL5 protein is important for building the connections that allow brain cells to talk to one another, reduced or altered protein function affects many systems in the body, making this a truly multisystem disorder [2].
Note: While this guide provides educational information, it is not a substitute for individualized medical advice. A printable seizure action plan and emergency contacts list should be created with your doctor, and you should never change or stop an anti-seizure medication without consulting your neurology team.
For most families, the journey with CDD begins with seizures that appear in the first few months of life. These seizures are typically refractory, meaning they do not respond well to standard medications and often require a combination of treatments to manage [3]. While the seizures are the most visible sign of the disorder, they exist alongside significant developmental delays and physical challenges. Most children with CDD experience low muscle tone, limited mobility, and Cortical Visual Impairment (CVI), a condition where the brain struggles to process what the eyes see [4][5].
Living with CDD also means managing a range of daily health concerns that happen “beyond the seizures.” Many children face persistent gastrointestinal issues, such as constipation and feeding difficulties, as well as significant sleep disturbances that can affect the entire family’s well-being [6][7]. Because these symptoms are so interconnected, effective care requires a holistic, multidisciplinary approach. This involves a team of specialists—including neurologists, gastroenterologists, and vision experts—working together to support the child’s nutrition, comfort, and sensory needs [8].
Treating CDD is a delicate balancing act. While the goal is to reduce seizures using both conventional anti-seizure medications and newer, targeted therapies like ganaxolone, the ultimate priority is always the child’s quality of life [9]. Success is measured not just by a lower seizure count, but by a child who is more alert, engaged, and comfortable in their daily life. As you navigate this diagnosis, remember that while the medical path is complex, the focus remains on supporting your child’s unique way of experiencing the world and celebrating every milestone they achieve [10].
In this guide
6 chapters
Understanding a CDKL5 Deficiency Disorder Diagnosis
Learn what a CDKL5 deficiency disorder diagnosis means, including seizures, development, genetic testing, vision, communication, and long-term care for families.
The Genetics and Biology of CDD
Learn how CDKL5 variants cause CDKL5 deficiency disorder, including X-inactivation, mosaicism, genotype–phenotype patterns, and differences from Rett syndrome.
Recognizing and Managing Seizure Emergencies
Learn seizure first aid for CDKL5 deficiency disorder, when to use rescue medicine, and breathing or aspiration warning signs requiring emergency help.
Seizure Types and Medical Treatments
Learn about seizure types and treatment for CDKL5 deficiency disorder, including ganaxolone, anti-seizure medicines, the ketogenic diet, VNS, and side effects.
Beyond Seizures: Managing the Multisystem Symptoms of CDD
Learn how CDKL5 deficiency disorder affects vision, feeding, sleep, breathing, movement, and growth, plus questions to discuss with your child’s care team.
Building Your Care Team and Navigating the Future
Learn how to build a CDKL5 deficiency disorder care team, use the CCSA to track progress, plan long-term health checks, and find support for caregivers.
Common questions in this guide
What is CDKL5 deficiency disorder?
How does the encephalopathy part of CDD affect development?
What symptoms can occur besides seizures in CDD?
Why are seizures in CDD often difficult to control?
What specialists should care for a child with CDD?
How do doctors decide whether a CDD treatment is helping?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How does the 'encephalopathy' part of my child's diagnosis influence their development differently than just the seizures alone?
- 2.What are the most important non-seizure symptoms we should begin monitoring right now?
- 3.Who will be the primary coordinator of our multidisciplinary team to ensure all our specialists are communicating?
- 4.How do we decide when a treatment's side effects are outweighing its benefits for my child's quality of life?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (10)
- 1
International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder.
Amin S, Monaghan M, Aledo-Serrano A, et al.
Frontiers in neurology 2022; (13()):874695 doi:10.3389/fneur.2022.874695.
PMID: 35795799 - 2
Epilepsy-Related CDKL5 Deficiency Slows Synaptic Vesicle Endocytosis in Central Nerve Terminals.
Kontaxi C, Ivanova D, Davenport EC, et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2023; (43(11)):2002-2020 doi:10.1523/JNEUROSCI.1537-22.2023.
PMID: 36759195 - 3
Seizure variables and their relationship to genotype and functional abilities in the CDKL5 disorder.
Fehr S, Wong K, Chin R, et al.
Neurology 2016; (87(21)):2206-2213 doi:10.1212/WNL.0000000000003352.
PMID: 27770071 - 4
CDKL5 deficiency disorder and other infantile-onset genetic epilepsies.
Daniels C, Greene C, Smith L, et al.
Developmental medicine and child neurology 2024; (66(4)):456-468 doi:10.1111/dmcn.15747.
PMID: 37771170 - 5
CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development.
Demarest ST, Olson HE, Moss A, et al.
Epilepsia 2019; (60(8)):1733-1742 doi:10.1111/epi.16285.
PMID: 31313283 - 6
The natural history of CDKL5 deficiency disorder into adulthood.
Aledo-Serrano A, Lewis-Smith D, Leonard H, et al.
medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.01.12.24318239.
PMID: 39867409 - 7
Long time polysomnographic sleep and breathing evaluations in children with CDKL5 deficiency disorder.
Hagebeuk EEO, Smits A, de Weerd A
Sleep medicine 2023; (103()):173-179 doi:10.1016/j.sleep.2023.02.003.
PMID: 36812861 - 8
Providing quality care for people with CDKL5 deficiency disorder: A European expert panel opinion on the patient journey.
Amin S, Møller RS, Aledo-Serrano A, et al.
Epilepsia open 2024; (9(3)):832-849 doi:10.1002/epi4.12914.
PMID: 38450883 - 9
Ganaxolone: A Review in Epileptic Seizures Associated with Cyclin-Dependent Kinase-Like 5 Deficiency Disorder.
Hoy SM
Paediatric drugs 2025; (27(1)):111-118 doi:10.1007/s40272-024-00670-6.
PMID: 39792341 - 10
Effects of ganaxolone on non-seizure outcomes in CDKL5 Deficiency Disorder: Double-blind placebo-controlled randomized trial.
Downs J, Jacoby P, Specchio N, et al.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2024; (51()):140-146 doi:10.1016/j.ejpn.2024.06.005.
PMID: 38959712
This CDKL5 deficiency disorder guide is for informational purposes only and does not constitute medical advice. Consult your child’s neurology team before changing seizure medicines or making care decisions.
Get notified when new evidence is published on CDKL5-deficiency disorder.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.